|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||4.5000 - 4.9700|
|52 Week Range||1.1000 - 9.2000|
|Beta (3Y Monthly)||-0.88|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 30, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.00|
CV Sciences, Inc. (CVSI) (the “Company”, “”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its industry-dominating brand, PlusCBD Oil™, announces its full support of the California Assembly’s Appropriations Committee’s unanimous passing of Assembly Bill 228 last week. Authored by Assemblymember Cecilia Aguiar-Curry (D-Winters), Assembly Bill 228 would expressly permit the retail sale of hemp-derived CBD in foods and supplements, and also in topical applications.
CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to announced that its industry-dominating PlusCBD Oil™ products were used in the first study to date examining the clinical benefit of CBD for the treatment of Post-Traumatic Stress Disorder (PTSD). The study, published in The Journal of Alternative and Complementary Medicine in April 2019, examined the effect of oral CBD administration on symptoms of PTSD in a series of 11 adult patients at an outpatient psychiatry clinic.
Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”).
LAS VEGAS, May 07, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products.
CV Sciences, Inc. (CVSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Not only has it transformed multi-billion-dollar industries including alcohol, health and wellness, cigarettes, and the retail industry, it's impacting food, too. Better, the U.S. FDA could provide a substantial boost to cannabis stocks in weeks. Lifestyle Delivery Systems Inc. (LDS)(LDSYF) just announced that its flagship product, Cannastrips will be presented at the Hall of Flowers (HoF) event.
CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its first quarter 2019 ended March 31, 2019, after the stock market closes on Wednesday, May 8, 2019. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day. The webcast of the conference call will be available on the Investor Relations section of the Company's website at https://ir.cvsciences.com/news-events and at http://public.viavid.com/index.php?id=134448.
Neiman Marcus is pushing ahead with CBD sales at some of its stores and online. Simon Property Group is partnering with Green Growth Brands to open 108 stores in its malls just in 2019. CVS will carry a line of CBD products in eight states, including California, Illinois, Colorado, and Alabama.
Horizons is the company behind the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)(OTC: HMLSF), which is one of the world's largest cannabis ETFs. “HMUS will be the first ETF in the world that is solely focused on providing exposure to companies with significant business activities in, or significant exposure to, the United States marijuana or hemp industries,” according to a statement.
LAS VEGAS, April 15, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products,.
HOUSTON, TX / ACCESSWIRE / April 12, 2019 / According to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 - a compound growth rate of 147%. Some of those companies include Lifestyle Delivery Systems Inc. (CSE: LDS)(OTC: LDSYF), Charlotte's Web Holdings Inc. (CN: CWEB)(OTC: CWBHF), and CV Sciences Inc. (NASDAQ: CVSI). Lifestyle Delivery Systems Inc.'s (LDS)(LDSYF) wholly owned subsidiary, CSPA Group just entered into an agreement to provide Mbioteq with a minimum of 120 liters of 85% THC raw distillate oil per month.
LAS VEGAS, April 10, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products, is.
The illicit cannabis industry is estimated at $50 billion yearly, much of which will move out of the shadows and become a legal market in the coming years. One research firm estimates the legal trade could be worth $21 billion by 2021. Item 9 Labs (INLB) could be one of these as they finish a major expansion project on their Arizona cannabis cultivation and production facility, doubling capacity.
HENDERSON, NV / ACCESSWIRE / March 26, 2019 / The electricity consumption of cannabis grow houses is staggering when compared to business and residential use. In 2015, the average electricity consumption ...
Leafbuyer Technologies Inc (OTC:LBUY), CV Sciences Inc (CVSI), MedMen Enterprises Inc (MMNFF) (MMEN.CN), and Terra Tech Corp (TRTC) represent 4 marijuana stocks leading the pack on Monday. More than ever, consumers depend on online resources to research the products they are interested in buying and, prior to Leafbuyer's platform, no reliable source existed for information on cannabis and related products. Leafbuyer Technologies Inc (OTC:LBUY) earlier this month announced that the total number of Greenlight platform users has reached nearly 80,000.
LAS VEGAS, March 21, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products.
Leafbuyer Technologies Inc (LBUY), CV Sciences Inc (CVSI), Trulieve Cannabis Corp (OTC PINK: TCNNF) (TRUL.CN), and GW Pharmaceuticals plc (NASDAQ:GWPH) represent 4 marijuana stocks leading the industry on Thursday. Nowadays, consumers depend on online resources to research the products they are interested in buying and, prior to Leafbuyer's platform, there hadn't been a reliable source for information on cannabis and related products. In recognition of this growing trend to do one's homework, Leafbuyer has become the authority on cannabis-related information.
Earlier this month, CV Sciences Inc (OTCMKTS: CVSI) released their financial results for the fiscal year ending on Dec. 31, 2018, posting record growth in both revenue and retail distribution. Indeed, CV Sciences finished out the fiscal year with a particularly strong fourth quarter. One of CV Sciences most popular product lines is PlusCBD Gold, which contains high concentrations of CBD instead of a mixture of CBD, CBDA, and other hemp-derived cannabinoids.
The cannabis industry has been extremely fortunate in the U.S. to see a massive amount of support across the nation. Nabis Holdings (INNPF) (NAB), Newstrike Brands Ltd (OTC PINK: NWKRF), CannTrust Holdings Inc (CTST) (TRST.TO), and CV Sciences Inc (CVSI) are 4 pot stocks that could test March highs. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.
HENDERSON, NV / ACCESSWIRE / March 15, 2019 / The biggest marijuana stocks get the most attention. But the global marijuana market is worth $150 billion annually and that suggests there's plenty of room ...
OTCQX and OTCQB Companies Featured at 2019 ROTH Conference NEW YORK , March 13, 2019 /PRNewswire/ -- OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, ...
Record full year revenue LAS VEGAS, March 12, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (“CV Sciences” or the “Company”) announced today its financial results for the year ended.
CORAL GABLES, FL / ACCESSWIRE / March 8, 2019 / Though the marijuana stock market and its accompanying industry are still very much in their infancy, cannabis companies have managed to attract significant investor attention during the course of the first few months of 2019. The primary focus of legislators now is convincing the federal government to remove marijuana's scheduled narcotic status, so that companies can access the domestic market in its entirety and offer consumers high-quality cannabis products. The future of the cannabis industry will be bright so long as public opinion surrounding marijuana legislation remains supportive and lawmakers continue to advocate for legalization.